Figure 5
CMV-specific T cells are of recipient origin after R+/D− HSCT but of both recipient and donor origin in the context of R+/D+ HSCT with mixed chimerism. (A) The upper panels illustrate the strategy used for sorting T-cell populations (pregated on CD3). Chimerism patterns are shown for donor and recipient, and subsequently for the selected T-cell populations at 6 months after HSCT. The CD8+ compartment is more skewed toward recipient chimerism than the CD4+ compartment, and the streptamer+ (CMV-specific) CD8+ cells show 100% recipient chimerism. (B) In contrast, in the setting of mixed chimerism after R+/D+ transplants, the CMV-reactive CD8+ T cells (streptamer+) come from both donor and recipient compartments, and the recipient chimerism levels were similar in the different cellular compartments (patient 4: CD4+ 4%, CD8+streptamer− 13%, CD8+streptamer+ 13%; patient 5: CD4+ 80%, CD8+streptamer− 86%, CD8+streptamer+ 85%).

CMV-specific T cells are of recipient origin after R+/D− HSCT but of both recipient and donor origin in the context of R+/D+ HSCT with mixed chimerism. (A) The upper panels illustrate the strategy used for sorting T-cell populations (pregated on CD3). Chimerism patterns are shown for donor and recipient, and subsequently for the selected T-cell populations at 6 months after HSCT. The CD8+ compartment is more skewed toward recipient chimerism than the CD4+ compartment, and the streptamer+ (CMV-specific) CD8+ cells show 100% recipient chimerism. (B) In contrast, in the setting of mixed chimerism after R+/D+ transplants, the CMV-reactive CD8+ T cells (streptamer+) come from both donor and recipient compartments, and the recipient chimerism levels were similar in the different cellular compartments (patient 4: CD4+ 4%, CD8+streptamer 13%, CD8+streptamer+ 13%; patient 5: CD4+ 80%, CD8+streptamer 86%, CD8+streptamer+ 85%).

Close Modal

or Create an Account

Close Modal
Close Modal